BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

280 related articles for article (PubMed ID: 33272737)

  • 1. Increase in the incidence of synchronous and metachronous peritoneal metastases in patients with colorectal cancer: A nationwide study.
    Lurvink RJ; Bakkers C; Rijken A; van Erning FN; Nienhuijs SW; Burger JW; Creemers GJ; Verhoef C; Lemmens VE; De Hingh IH
    Eur J Surg Oncol; 2021 May; 47(5):1026-1033. PubMed ID: 33272737
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The impact of an open or laparoscopic approach on the development of metachronous peritoneal metastases after primary resection of colorectal cancer: results from a population-based cohort study.
    Lurvink RJ; Rijken A; Bakkers C; Lemmens VE; de Reuver PR; Tuynman JB; Kok NF; Nienhuijs SW; van Erning FN; de Hingh IHJT
    Surg Endosc; 2022 Sep; 36(9):6551-6557. PubMed ID: 35059835
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The impact of body weight on the development of peritoneal metastases in colorectal cancer patients: results from a nationwide cohort study.
    van de Vlasakker VCJ; van Erning FN; Lurvink RJ; de Hingh IHJT; Nienhuijs SW
    World J Surg Oncol; 2023 Oct; 21(1):328. PubMed ID: 37845754
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Metachronous peritoneal carcinomatosis after curative treatment of colorectal cancer.
    van Gestel YR; Thomassen I; Lemmens VE; Pruijt JF; van Herk-Sukel MP; Rutten HJ; Creemers GJ; de Hingh IH
    Eur J Surg Oncol; 2014 Aug; 40(8):963-9. PubMed ID: 24183168
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Treatment Strategies and Prognosis of Patients With Synchronous or Metachronous Colorectal Peritoneal Metastases: A Population-Based Study.
    Bakkers C; Lurvink RJ; Rijken A; Nienhuijs SW; Kok NF; Creemers GJ; Verhoef C; Lemmens VE; van Erning FN; De Hingh IH
    Ann Surg Oncol; 2021 Dec; 28(13):9073-9083. PubMed ID: 34076807
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Synchronous polyps predict metachronous colorectal lesions after curative resection of colorectal cancer.
    Pozza A; Ruffolo C; Fiorot A; Padoan L; Erroi F; Massani M; Caratozzolo E; Bonariol L; Ferrara F; Norberto L; Castoro C; Bassi N; Scarpa M
    Acta Chir Belg; 2016 Aug; 116(4):225-230. PubMed ID: 27426670
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Risk factors for appendiceal and colorectal peritoneal metastases.
    Enblad M; Graf W; Birgisson H
    Eur J Surg Oncol; 2018 Jul; 44(7):997-1005. PubMed ID: 29576463
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Impact of absence of consensual cutoff time distinguishing between synchronous and metachronous metastases: illustration with colorectal cancer.
    Willem H; Jooste V; Boussari O; Romain G; Bouvier AM
    Eur J Cancer Prev; 2019 May; 28(3):167-172. PubMed ID: 29738323
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Metachronous advanced neoplasia after submucosal invasive colorectal cancer resection.
    Minamide T; Ikematsu H; Murano T; Kadota T; Shinmura K; Yoda Y; Hori K; Ito M; Yano T
    Sci Rep; 2021 Jan; 11(1):1869. PubMed ID: 33479474
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Synchronous and Metachronous Peritoneal Metastases in Patients with Left-Sided Obstructive Colon Cancer.
    Veld JV; Wisselink DD; Amelung FJ; Consten ECJ; de Wilt JHW; de Hingh I; Bemelman WA; van Hooft JE; Tanis PJ;
    Ann Surg Oncol; 2020 Aug; 27(8):2762-2773. PubMed ID: 32170481
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Incidence and risk factors of metachronous colorectal neoplasm after curative resection of colorectal cancer in Korean patients.
    Lee SY; Kim BC; Han KS; Hong CW; Sohn DK; Park SC; Kim SY; Baek JY; Chang HJ; Kim DY; Oh JH
    J Dig Dis; 2014 Jul; 15(7):367-76. PubMed ID: 24773758
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Higher incidence of metachronous advanced neoplasia in patients with synchronous advanced neoplasia and left-sided colorectal resection for colorectal cancer.
    Yabuuchi Y; Imai K; Hotta K; Ito S; Kishida Y; Yamaguchi T; Shiomi A; Kinugasa Y; Yoshida M; Tanaka M; Kawata N; Kakushima N; Takizawa K; Ishiwatari H; Matsubayashi H; Ono H
    Gastrointest Endosc; 2018 Aug; 88(2):348-359.e1. PubMed ID: 29574125
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Synchronous and metachronous colorectal cancers: distinct disease entities or different disease courses?
    Huang CS; Yang SH; Lin CC; Lan YT; Chang SC; Wang HS; Chen WS; Lin TC; Lin JK; Jiang JK
    Hepatogastroenterology; 2015; 62(138):286-90. PubMed ID: 25916050
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Impact of Synchronous Versus Metachronous Onset of Colorectal Peritoneal Metastases on Survival Outcomes After Cytoreductive Surgery (CRS) with Hyperthermic Intraperitoneal Chemotherapy (HIPEC): A Multicenter, Retrospective, Observational Study.
    Hentzen JEKR; Rovers KP; Kuipers H; van der Plas WY; Been LB; Hoogwater FJH; van Ginkel RJ; Hemmer PHJ; van Dam GM; de Hingh IHJT; Kruijff S
    Ann Surg Oncol; 2019 Jul; 26(7):2210-2221. PubMed ID: 30877495
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Incidence, prevalence and risk factors for peritoneal carcinomatosis from colorectal cancer.
    Segelman J; Granath F; Holm T; Machado M; Mahteme H; Martling A
    Br J Surg; 2012 May; 99(5):699-705. PubMed ID: 22287157
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Predictive factors of synchronous colorectal peritoneal metastases: Development of a nomogram and study of its utilities using decision curve analysis.
    Mo S; Dai W; Xiang W; Li Q; Wang R; Cai G
    Int J Surg; 2018 Jun; 54(Pt A):149-155. PubMed ID: 29730071
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Epidemiology and familial risk of synchronous and metachronous colorectal cancer: a population-based study in Utah.
    Samadder NJ; Curtin K; Wong J; Tuohy TM; Mineau GP; Smith KR; Pimentel R; Pappas L; Boucher K; Garrido-Laguna I; Provenzale D; Burt RW
    Clin Gastroenterol Hepatol; 2014 Dec; 12(12):2078-84.e1-2. PubMed ID: 24768809
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Characteristics of synchronous and metachronous duodenal tumors and association with colorectal cancer: a supplementary analysis.
    Yamasaki Y; Kato M; Takeuchi Y; Hoteya S; Oyama T; Nonaka S; Yoshimizu S; Yoshida M; Ohata K; Miura Y; Hara Y; Tsuji S; Dohi O; Ueyama H; Kurahara K; Tashima T; Abe N; Mitsuhashi T; Nakayama A; Oda I; Yahagi N
    J Gastroenterol; 2023 May; 58(5):459-469. PubMed ID: 36847918
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Synchronous and Metachronous Colorectal Cancers: Distinct Disease Entities or Different Disease Courses?
    Huang CS; Yang SH; Lin CC; Lan YT; Chang SC; Wang HS; Chen WS; Lin TC; Lin JK; Jiang JK
    Hepatogastroenterology; 2015 Jun; 62(140):838-42. PubMed ID: 26902012
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Impact of time of occurrence of liver metastases (synchronous vs. metachronous) on early postoperative outcome and long-term survival of colorectal cancer patients].
    Bova R; Kamphues C; Neuhaus P; Puhl G
    Zentralbl Chir; 2014 Apr; 139(2):220-5. PubMed ID: 23846535
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.